Section Arrow
CSTL.NASDAQ
- Castle Biosciences
Quotes are at least 15-min delayed:2025/07/02 20:22 EDT
Last
 20.01
-0.33 (-1.62%)
Day High 
20.565 
Prev. Close
20.34 
1-M High
20.63 
Volume 
337.49K 
Bid
19.25
Ask
21.37
Day Low
20 
Open
20.21 
1-M Low
15.565 
Market Cap 
587.26M 
Currency USD 
P/E 27.5 
%Yield -- 
10-SMA 19.43 
20-SMA 18.71 
50-SMA 18.2 
52-W High 35.84 
52-W Low 15.45 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.19/-2.22
Enterprise Value
611.66M
Balance Sheet
Book Value Per Share
15.25
Cash Flow
Cash Flow Yield
0.11
Income Statement
Total Revenue
332.07M
Operating Revenue Per Share
6.65
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.23+0.15+2.95%879PE
BIAFbioAffinity Technologies0.29+0.0265+10.06%-- 
DHRDanaher Corp202.5+1.4+0.70%38.97PE
OPKOPKO Health1.34+0.01+0.75%-- 
TMOThermo Fisher Scientific427.76+6.29+1.49%24.72PE
Quotes are at least 15-min delayed:2025/07/02 20:22 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.